Determining whether Jushi stock represents a sound investment depends heavily on an investor's risk tolerance, speculative horizon, and outlook on federal cannabis legalization reform. The stock exhibits high volatility, trading at micro-cap valuations with compressed liquidity compared to broader healthcare sectors. While potential future regulatory reform or federal rescheduling could unlock major upside catalysts, current investors must weigh ongoing dilution risks, regulatory compliance costs, and financial headwinds.